Related Experiment Video
Updated: Feb 7, 2026

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.7K
Post-bariatric Hypoglycemia Management: A Gulf Cooperation Council Consensus Statement.
Elamin Abdelgadir1,2, Fauzia Rashid1,2, Fatheya Al Awadi1,2
1Mohamed Bin Rashid University, Dubai 505055, UAE.
Journal of the Endocrine Society
|February 6, 2026
Summary
Post-bariatric hypoglycemia (PBH) management is inconsistent due to complex causes and lack of standard treatments. This consensus provides unified, evidence-based guidelines for diagnosis and care.
Area of Science:
- Metabolic and Bariatric Surgery
- Endocrinology
- Gastroenterology
Background:
- Post-bariatric hypoglycemia (PBH) is a significant late complication following metabolic and bariatric surgery.
- PBH presents with a spectrum of symptoms, from mild to severe neuroglycopenic events.
- Current PBH management is heterogeneous due to complex pathophysiology and lack of standardized protocols.
Purpose of the Study:
- To establish a unified, evidence-based, and patient-centered management protocol for PBH.
- To standardize the diagnosis and treatment of PBH across clinical practice.
- To address the heterogeneity in PBH management approaches.
Main Methods:
- A panel of 16 international experts (GCC and Europe) conducted a literature review.
- Consensus statements were developed using the Delphi method.
- 45 statements were agreed upon, covering diagnosis, dietary management, education, and treatment.
Main Results:
- Consensus was reached on 45 statements for comprehensive PBH management.
- Guidelines cover diagnosis, dietary adjustments, patient education, and pharmacological treatment.
- Special considerations for pregnancy, long-term monitoring, and clinical practice are included.
Conclusions:
- Implementation of these consensus statements will standardize PBH management.
- Significant gaps remain, including the need for PBH-specific therapies and robust clinical trials.
- Future research should focus on addressing these identified gaps in PBH care.
Related Concept Videos
Cooperative Allosteric Transitions
8.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.8K
Cooperative Allosteric Transitions
3.1K
3.1K
Cooperative Allosteric Transitions
2.7K
2.7K
Cooperative Binding of Transcription Regulators
7.4K
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.4K
Cooperative Binding of Transcription Regulators
2.6K
2.6K
Hypoglycemia and Glucagon
992
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
992

